Sign inJoin waitlistJoin the waitlist

Bruno Bastos

Physician · Mount Sinai Medical Center of Florida, Inc

Credentials: · · · · · ·

History

Mount Sinai Medical Center of Florida, Inc
2024–Present

HCA Florida JFK Hospital/University of Miami Miller School of Medicine GME Consortium
2009–2012
Internal Medicine
HCA Florida JFK Hospital/University of Miami Miller School of Medicine GME Consortium
2006–2009
Harvard Medical School
2002–2006

Research

A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)
Clinical Cancer Research · 2021 · 82 citations
Phase I safety, pharmacokinetic, and pharmacodynamic study of ENMD-2076, a novel angiogenic and Aurora kinase inhibitor, in patients with advanced solid tumors
Clinical Cancer Research · 2011 · 59 citations
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)
Clinical Cancer Research · 2020 · 53 citations

Pamela Munster
5 papers
AA
Ajjai Alva
2 papers
Amir Goldkorn
2 papers
Benedito Carneiro
2 papers
Brian Labadie
2 papers · 2 as a fellow
CN
Chadi Nabhan
2 papers
Dan Theodorescu
2 papers
Daniel Olson
2 papers · 1 as a fellow
EH
Elisabeth Heath
2 papers
Emmanuel Antonarakis
2 papers
FG
Francis Giles
2 papers
GM
Gary Macvicar
2 papers

Clinical trials

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2032
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Site PI · Recruiting · Phase 3
Canadian Cancer Trials Group
2025–2031
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Site PI · Recruiting · Phase 1, Phase 2
Pathos AI, Inc.
2025–2029
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2023–2041